<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39394427</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1530-0447</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Oct</Month><Day>12</Day></PubDate></JournalIssue><Title>Pediatric research</Title><ISOAbbreviation>Pediatr Res</ISOAbbreviation></Journal><ArticleTitle>Association between SARS-CoV-2 infection before the age of two and child development.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41390-024-03614-5</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">To compare the differences in child development between children who contracted COVID-19 after February 1st, 2022, the period when the B.1.1.529 variant outbreak began to peak in Thailand, and those who did not.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A prospective cohort study was conducted in an outpatient pediatric clinic at a tertiary hospital in southern Thailand. COVID-19 was diagnosed based on the results of an FDA-approved antigen test or RT-PCR using a swab sample collected from the nasopharynx, nose, or throat. Child development was assessed using the Ages and Stages Questionnaire, Third Edition (ASQ-3).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of the 336 participants, 180 (53.6%) had a history of COVID-19. Almost all of them had mild COVID-19. The mean (SD) age at infection was 1.3 (0.3) years, and the median (IQR) duration between infection and ASQ-3 assessment was 193.5 (167.8, 216.2) days. The ASQ-3 scores at the ages of 18 (n = 166; 90 COVID-19 positive) and 24 months (n = 170; 90 COVID-19 positive) revealed no statistically significant differences between children with and without a history of COVID-19. Both groups had comparable proportions of developmental scores &lt;1 SD below the mean.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Mild COVID-19 in young children did not increase the risk of developmental delays.</AbstractText><AbstractText Label="IMPACT" NlmCategory="CONCLUSIONS">This cohort study was conducted during the Omicron pandemic. Of the 336 children, no clinical or statistically significant differences were observed in the scores of the Ages &amp; Stages Questionnaire, Third Edition, at 18 or 24 months of age among the 180 participants with a history of mild SARS-CoV-2 infection, at an average of 6 months post-infection, and those without. The findings suggest that mild SARS-CoV-2 infection before the age of 2 years is not associated with developmental delays. Strategies to prevent severe SARS-CoV-2 infection in young children, especially COVID-19 immunization, need to be highlighted.</AbstractText><CopyrightInformation>© 2024. The Author(s), under exclusive licence to the International Pediatric Research Foundation, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tassanakijpanich</LastName><ForeName>Nattaporn</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Division of Pediatrics, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chumchuen</LastName><ForeName>Kemmapon</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Clinical Research and Medical Data Science, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Worachotekamjorn</LastName><ForeName>Juthamas</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Pediatrics, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laoprasopwattana</LastName><ForeName>Kamolwish</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Pediatrics, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand. kamolwish@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Pediatr Res</MedlineTA><NlmUniqueID>0100714</NlmUniqueID><ISSNLinking>0031-3998</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>12</Day><Hour>9</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>12</Day><Hour>9</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>11</Day><Hour>23</Hour><Minute>37</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39394427</ArticleId><ArticleId IdType="doi">10.1038/s41390-024-03614-5</ArticleId><ArticleId IdType="pii">10.1038/s41390-024-03614-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Khemiri, H., Ayouni, K., Triki, H. &amp; Haddad-Boubaker, S. SARS-CoV-2 infection in pediatric population before and during the Delta (B.1.617.2) and Omicron (B.1.1.529) variants era. Virol. J. 19, 144 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-022-01873-4</ArticleId><ArticleId IdType="pubmed">36076271</ArticleId><ArticleId IdType="pmc">9452867</ArticleId></ArticleIdList></Reference><Reference><Citation>Sumner, M. W. et al. Comparison of symptoms associated with SARS-CoV-2 variants among children in Canada. JAMA Netw. Open 6, e232328 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2023.2328</ArticleId><ArticleId IdType="pubmed">36892839</ArticleId><ArticleId IdType="pmc">9999248</ArticleId></ArticleIdList></Reference><Reference><Citation>Microsoft power BI (accessed 18 May 2023); https://app.powerbi.com/view?r=eyJrIjoiYWRiZWVkNWUtNmM0Ni00MDAwLTljYWMtN2EwNTM3YjQzYmRmIiwidCI6ImY2MTBjMGI3LWJkMjQtNGIzOS04MTBiLTNkYzI4MGFmYjU5MCIsImMiOjh9 .</Citation></Reference><Reference><Citation>A clinical case definition for post COVID-19 condition in children and adolescents by expert consensus (accessed 16 February 2023); https://www.who.int/publications-detail-redirect/WHO-2019-nCoV-Post-COVID-19-condition-CA-Clinical-case-definition-2023-1 .</Citation></Reference><Reference><Citation>Douaud, G. et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature 604, 697–707 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04569-5</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId><ArticleId IdType="pmc">9046077</ArticleId></ArticleIdList></Reference><Reference><Citation>Yachou, Y., El Idrissi, A., Belapasov, V. &amp; Ait Benali, S. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients. Neurol. Sci. 41, 2657–2669 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-020-04575-3</ArticleId><ArticleId IdType="pubmed">32725449</ArticleId><ArticleId IdType="pmc">7385206</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou, Z., Kang, H., Li, S. &amp; Zhao, X. Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms. J. Neurol. 267, 2179–2184 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-09929-7</ArticleId><ArticleId IdType="pubmed">32458193</ArticleId><ArticleId IdType="pmc">7249973</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai, I., Manchanda, R., Kumar, N., Tiwari, A. &amp; Kumar, M. Neurological manifestations of coronavirus disease 2019: exploring past to understand present. Neurol. Sci. 42, 773–785 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-020-04964-8</ArticleId><ArticleId IdType="pubmed">33428055</ArticleId><ArticleId IdType="pmc">7798003</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso, D. et al. Preliminary evidence on long COVID in children. Acta Paediatr. 110, 2208–2211 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.15870</ArticleId><ArticleId IdType="pubmed">33835507</ArticleId><ArticleId IdType="pmc">8251440</ArticleId></ArticleIdList></Reference><Reference><Citation>Behnood, S. A. et al. Persistent symptoms following SARS-CoV-2 infection amongst children and young people: a meta-analysis of controlled and uncontrolled studies. J. Infect. 84, 158–170 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.11.011</ArticleId><ArticleId IdType="pubmed">34813820</ArticleId></ArticleIdList></Reference><Reference><Citation>Borch, L., Holm, M., Knudsen, M., Ellermann-Eriksen, S. &amp; Hagstroem, S. Long COVID symptoms and duration in SARS-CoV-2 positive children – a nationwide cohort study. Eur. J. Pediatr. 181, 1597–1607 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-021-04345-z</ArticleId><ArticleId IdType="pubmed">35000003</ArticleId><ArticleId IdType="pmc">8742700</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez-Romieu, A. C. et al. Prevalence of select new symptoms and conditions among persons aged younger than 20 years and 20 years or older at 31 to 150 days after testing positive or negative for SARS-CoV-2. JAMA Netw. Open 5, e2147053 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.47053</ArticleId><ArticleId IdType="pubmed">35119459</ArticleId><ArticleId IdType="pmc">8817203</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon, S. et al. Long-COVID in children and adolescents: a systematic review and meta-analyses. Sci. Rep. 12, 9950 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-13495-5</ArticleId><ArticleId IdType="pubmed">35739136</ArticleId><ArticleId IdType="pmc">9226045</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban, F. et al. Fatigue and cognitive impairment in post-COVID-19 Syndrome: A systematic review and meta-analysis. Brain Behav. Immun. 101, 93–135 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.12.020</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet, M. et al. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients. Lancet Psychiatry 9, 815–827 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(22)00260-7</ArticleId><ArticleId IdType="pubmed">35987197</ArticleId><ArticleId IdType="pmc">9385200</ArticleId></ArticleIdList></Reference><Reference><Citation>Lenroot, R. K. &amp; Giedd, J. N. Brain development in children and adolescents: insights from anatomical magnetic resonance imaging. Neurosci. Biobehav. Rev. 30, 718–729 (2006).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neubiorev.2006.06.001</ArticleId><ArticleId IdType="pubmed">16887188</ArticleId></ArticleIdList></Reference><Reference><Citation>Felsenfeld, S., Broen, P. A. &amp; McGue, M. A 28-year follow-up of adults with a history of moderate phonological disorder: educational and occupational results. J. Speech Hear. Res. 37, 1341–1353 (1994).</Citation><ArticleIdList><ArticleId IdType="doi">10.1044/jshr.3706.1341</ArticleId><ArticleId IdType="pubmed">7877292</ArticleId></ArticleIdList></Reference><Reference><Citation>Young, A. R. et al. Young adult academic outcomes in a longitudinal sample of early identified language impaired and control children. J. Child. Psychol. Psychiatry 43, 635–645 (2002).</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1469-7610.00052</ArticleId><ArticleId IdType="pubmed">12120859</ArticleId></ArticleIdList></Reference><Reference><Citation>Squires, J., Twombly, E., Bricker, D. &amp; Potter, L. The ASQ-3 User’s Guide for Ages and Stages Questionnaires 3rd edn (Paul H. Brookes Publishing Co, 2009).</Citation></Reference><Reference><Citation>Cohen, J. A power primer. Psychol. Bull. 112, 155–159 (1992).</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/0033-2909.112.1.155</ArticleId><ArticleId IdType="pubmed">19565683</ArticleId></ArticleIdList></Reference><Reference><Citation>The National Institute of Child Development. Development Situation of Early Childhood in Thailand in 2019. (Ministry of Public Health, Department of Health, Nonthaburi, 2019).</Citation></Reference><Reference><Citation>Rithipukdee, N. &amp; Kusol, K. Factors associated with the suspected delay in the language development of early childhood in Southern Thailand. Children 9, 662 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/children9050662</ArticleId><ArticleId IdType="pubmed">35626839</ArticleId><ArticleId IdType="pmc">9139734</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuengfoo, A. Concurrent validity of the ages and stages questionnaires. 3rd ed (ASQ-3 Thai-version) with Bayley-3 in developmental screening of children at 9,18 and 24 months. Thai. J. Pediatr. 56, 114–125 (2017).</Citation></Reference><Reference><Citation>Fuengfoo, A., Sakulnoom, K., Owjinda, S. &amp; Piromkit, A. The feasibility of the Ages &amp; Stages Questionnaires, (ASQ-3. Thai version) for the assessment of child development in Thailand. J. Med. Assoc. Thai. 103, 1247–1254 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.35755/jmedassocthai.2020.12.10302</ArticleId></ArticleIdList></Reference><Reference><Citation>https://redcap.psu.ac.th/redcap_v13.1.32/Design/online_designer.php?pid=34 REDCap (accessed 23 May 2023).</Citation></Reference><Reference><Citation>R: A Language and Environment for Statistical Computing https://www.R-project.org/</Citation></Reference><Reference><Citation>Shuffrey, L. C. et al. Association of birth during the COVID-19 pandemic with neurodevelopmental status at 6 months in infants with and without in utero exposure to maternal SARS-CoV-2 infection. JAMA Pediatr. 176, e215563 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2021.5563</ArticleId><ArticleId IdType="pubmed">34982107</ArticleId><ArticleId IdType="pmc">8728661</ArticleId></ArticleIdList></Reference><Reference><Citation>Edlow, A. G. et al. Sex-specific neurodevelopmental outcomes among offspring of Mothers With SARS-CoV-2 infection during pregnancy. JAMA Netw. Open 6, e234415 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2023.4415</ArticleId><ArticleId IdType="pubmed">36951861</ArticleId><ArticleId IdType="pmc">10037162</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato, K., Fukai, T., Fujisawa, K. K. &amp; Nakamuro, M. Association between the COVID-19 pandemic and early childhood development. JAMA Pediatr. 177, 930–938 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2023.2096</ArticleId><ArticleId IdType="pubmed">37428500</ArticleId><ArticleId IdType="pmc">10334298</ArticleId></ArticleIdList></Reference><Reference><Citation>Hessami, K. et al. COVID-19 pandemic and infant neurodevelopmental impairment: a systematic review and meta-analysis. JAMA Netw. Open 5, e2238941 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.38941</ArticleId><ArticleId IdType="pubmed">36306133</ArticleId><ArticleId IdType="pmc">9617178</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu, T. et al. Effects of SARS-CoV-2 infection during late pregnancy on early childhood development: a prospective cohort study. Front. Pediatr. 9, 750012, https://doi.org/10.3389/fped.2021.750012 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2021.750012</ArticleId><ArticleId IdType="pubmed">34888266</ArticleId><ArticleId IdType="pmc">8650051</ArticleId></ArticleIdList></Reference><Reference><Citation>Cisneros-Franco, J. M., Voss, P., Thomas, M. E. &amp; de Villers-Sidani, E. Chapter 8. Critical periods of brain development. in Handbook of Clinical Neurology (eds Gallagher, A., Bulteau, C., Cohen, D. &amp; Michaud, J. L.) (Elsevier, 2020).</Citation></Reference><Reference><Citation>Bunyavanich, S., Do, A. &amp; Vicencio, A. Nasal gene expression of angiotensin-converting enzyme 2 in children and adults. JAMA 323, 2427–2429 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.8707</ArticleId><ArticleId IdType="pubmed">32432657</ArticleId><ArticleId IdType="pmc">7240631</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>